These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11367256)
1. Anti-HIV therapies early in the pipeline. Bartnof HS BETA; 1999; 12(4):57. PubMed ID: 11367256 [TBL] [Abstract][Full Text] [Related]
2. New antiretroviral agents. Gallant JE Hopkins HIV Rep; 1999 Mar; 11(2):3, 12. PubMed ID: 11366248 [TBL] [Abstract][Full Text] [Related]
3. Anti-HIV therapy trials: new studies and follow-up of existing trials. Bartnof HS BETA; 1999; 12(4):58-60. PubMed ID: 11367257 [TBL] [Abstract][Full Text] [Related]
4. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008]. Zheng PR; Xue H; Xiao ZY; Liu G Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology: a progress report. Flexner C Hopkins HIV Rep; 1999 Mar; 11(2):13-4, 16. PubMed ID: 11366246 [TBL] [Abstract][Full Text] [Related]
6. The development of anti-HIV-1 drugs. Lu XF; Chen ZW Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415 [TBL] [Abstract][Full Text] [Related]
7. Conference updates show promising drug data. AIDS Alert; 1997 Nov; 12(11):125-6. PubMed ID: 11364769 [TBL] [Abstract][Full Text] [Related]
8. New anti-HIV drug interactions, toxicities, and dosing options. Bartnof HS BETA; 1999; 12(4):60-3, 66. PubMed ID: 11367260 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy. Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083 [TBL] [Abstract][Full Text] [Related]
12. After the drugs: what's next? Schouten JT Res Initiat Treat Action; 1998 Dec; 4(7):9-10. PubMed ID: 11366085 [TBL] [Abstract][Full Text] [Related]
13. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS). De Clercq E Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of resistance to antiretroviral drugs. Vella S AIDS Clin Care; 1997 Jun; 9(6):45-7, 49, 52. PubMed ID: 11364354 [TBL] [Abstract][Full Text] [Related]
15. New drugs for old. Winston A; Stebbing J J HIV Ther; 2005 Mar; 10(1):11-6. PubMed ID: 15951729 [TBL] [Abstract][Full Text] [Related]
16. New targets and new drugs in the treatment of HIV. López-Aldeguer J; Aguirrebengoa K; Arribas JR; Esté JA; Kindelán JM Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():25-40. PubMed ID: 16373002 [TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885 [No Abstract] [Full Text] [Related]
19. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections. Pauwels R Curr Opin Pharmacol; 2004 Oct; 4(5):437-46. PubMed ID: 15351347 [TBL] [Abstract][Full Text] [Related]
20. Candidate antiretroviral agents for use in postexposure prophylaxis. Saag MS Am J Med; 1997 May; 102(5B):25-31. PubMed ID: 9845493 [No Abstract] [Full Text] [Related] [Next] [New Search]